Visionary Ventures is a venture capital fund based in Newport Beach, California, that invests in life sciences, ophthalmology, and medical aesthetics. The firm leverages an information advantage strategy to connect capital and insight with promising startups from Series A through commercialization.
42% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $52.4M (across 15 rounds with reported amounts).
Portfolio
15
Fund Size
$114M
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
19 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| IIantrek | Series C | — | Jan 2025 |
 Orasis | Series D | $78M | Oct 2024 |
| OORASIS Pharmaceuticals | Unknown | $78M | Oct 2024 |
 Pelage Pharmaceuticals | Series A | $14M | Feb 2024 |
 ONL Therapeutics | Unknown | $65M | Jan 2024 |
 Re-Vana Therapeutics | Series A | $11.9M | Nov 2022 |
| AAurion | Series C | $120M | Apr 2022 |
 Aurion Biotech | Series A | $120M | Jan 2022 |
| AAurion | Series A | — | Jan 2022 |
 TearClear | Series B | $22M | Aug 2020 |
 Tarsus Pharmaceuticals | Series B | $60M | Jan 2020 |
| OORASIS Pharmaceuticals | Unknown | $30M | Jan 2020 |
| TearClear | Series A | $4.5M | Jan 2017 |
 Sydnexis | Series B | $45M | — |
| Aurion Biotech | Series B | — | — |
| RRECCE | Unknown | $4M | — |
| PPelage | Series B | $120M | — |
 Tear Film Innovations | Growth | — | — |
| OOrasis Pharmaceuticals Ltd. | Series B | $13M | — |
Top Co-Investors
Bluestem Capital Company6 shared
Sequoia Capital4 shared
Catalio Capital Management3 shared
YK Bioventures2 shared
Main Street Advisors2 shared
Maverick Ventures2 shared
Johnson & Johnson Innovation2 shared
LifeSci Venture Partners2 shared
Deerfield2 shared
e2vc2 shared
GV1 shared
Aperture Venture Partners1 shared
Frazier Healthcare Partners1 shared
Vivo Capital1 shared
Arbor Ventures1 shared
aMoon1 shared
Trinity Capital Inc.1 shared
Sectoral Asset Management1 shared
Civilization Ventures1 shared
Longitude Capital1 shared
Last updated: 8 September 2026